Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-valvular Atrial Fibrillation (NVAF)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05560204
What this trial is testing

Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet

Who this might be right for
Combined Pulsed-field Ablation (PFA)
Prince of Wales Hospital, Shatin, Hong Kong 200
Not applicableStudy completedNCT05438888
What this trial is testing

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 77,814
Not applicableStudy completedNCT04722679
What this trial is testing

Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.

Who this might be right for
Non-Valvular Atrial Fibrillation
Bayer 103
Not applicableNot Yet RecruitingNCT07396493
What this trial is testing

A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)High Risk of Stroke
Shanghai Zhongshan Hospital 306
Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Not applicableStudy completedNCT02951039
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 3,008
Not applicableStudy completedNCT03746301
What this trial is testing

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 924
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Not applicableLooking for participantsNCT04298723
What this trial is testing

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Who this might be right for
Intracranial HemorrhagesAtrial Fibrillation (AF)Atrial Flutter
Jena University Hospital 530
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableLooking for participantsNCT05204212
What this trial is testing

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent
Prof. Dr. med. Ingo Eitel 430
Not applicableStudy completedNCT03285373
What this trial is testing

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,008
Not applicableStudy completedNCT04099238
What this trial is testing

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Who this might be right for
Atrial Fibrillation
Bayer 3,739
Not applicableUnknownNCT03554837
What this trial is testing

Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF

Who this might be right for
Atrial Fibrillation
Samsung Medical Center 2,562
Not applicableStudy completedNCT03247569
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company 300
Not applicableStudy completedNCT02485873
What this trial is testing

Real-Life Evidence on Stroke Prevention in SPAF

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)
Bayer 8,607
Not applicableStudy completedNCT05038228
What this trial is testing

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Who this might be right for
Atrial Fibrillation
Pfizer 1
Early research (Phase 1)Active Not RecruitingNCT06725355
What this trial is testing

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
HK inno.N Corporation 60
Post-approval studies (Phase 4)UnknownNCT03234114
What this trial is testing

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Who this might be right for
Acute Coronary Syndrome (ACS)Non-valvular Atrial Fibrillation (NVAF)
The First Affiliated Hospital with Nanjing Medical University 3,746
Not applicableStudy completedNCT06606275
What this trial is testing

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis

Who this might be right for
End-Stage Kidney Disease (ESKD)Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)
Abu Dhabi Health Services Company 67
Next Page